Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Impact of Infant and Maternal Immunoprophylaxis on Hospitalisation for Respiratory Syncytial Virus in the Australian Capital Territory: A Population-based Interrupted Time Series Study

NCT07164430 is registered in ClinicalTrials.gov with Nicola Irwin as lead sponsor.

NCT NCT07164430
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07164430 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Impact of Infant and Maternal Immunoprophylaxis on Hospitalisation for Respiratory Syncytial Virus in the Australian Capital Territory: A Population-based Interrupted Time Series Study
Lead sponsor
Nicola Irwin
Phase
Observational
Overall status
Completed
Start date
September 22, 2025
Completion date
January 31, 2026
Enrollment
2,792 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

respiratory syncytial virus (rsv) infection, respiratory syncytial virus hospitalizations, respiratory syncytial virus immunization